Clinical Trial Update: Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial of Onercept for moderate to severe plaque psoriasis, including treatment and re-treatment, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• Onercept

Snippet

Sponsor: EMD Serono | Conditions: Arthritis, Psoriatic | Phase 3 | Status: TERMINATED